A phase I study of adoptive tumor-infiltrating lymphocyte (TIL, BST02) therapy in patients with advanced liver cancer.

Authors: Yaojun Zhang, Jinbin Chen, Juncheng Wang, Mingyu Liu, Zhezhao Liang, Deping Han, Xi Zhang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e16198

Source: Full article

---

Abstract

e16198